MMDS Aquires USA Patent Rights for Medical Marijuana Patch

Medical Marijuana Delivery Systems LLC has acquired the United States Patent Rights to a perfected technology for the transcutaneous delivery of medical marijuana/ tetrahydrocannabinol and other secondary marijuana metabolites. There are many members of the general population for whom the therapeutic benefits of medical marijuana would be a welcome augment to current pain management options, however, for any number of reasons including, but not limited to: (i) persons who cannot draw smoke into their lungs because of the malady from which they suffer; (ii) persons who are either too young or too elderly for normal medical marijuana therapy delivery modalities; (iii) persons who have never smoked in their lives and do not want start smoking even if the smoke is therapeutic; and (iv) general societal misgivings about marijuana because of the perceived social stigma attributed to marijuana use; medical marijuana therapy is not an option. These members of our society as well as other eligible medical marijuana patients, now have a viable and societally acceptable alternative available to them; the Medical Marijuana Medicinal Patch. The Patch is the first exclusively controlled and clearly medicinal departure from marijuana’s age old delivery modality of smoking and therefore (i) will block any black market product proliferation and non-taxable profiteering; and (ii) will open the door for Medical Marijuana DElivery Systems’s research and development of other purely holistic delivery modalities.